SCAMP5 regulates membrane dynamics and interacts with calcium channels and autophagy pathways. Studies highlight its dual role in:
Calcium channel modulation: SCAMP5 suppresses T-type calcium currents (Ca<sub>v</sub>3.1, Ca<sub>v</sub>3.2, Ca<sub>v</sub>3.3) by reducing channel expression in the plasma membrane .
Autophagy-exosome coordination: SCAMP5 inhibits autophagosome-lysosome fusion while promoting exosome-mediated protein secretion, a mechanism critical under cellular stress .
Recombinant Xenopus tropicalis SCAMP5 is produced using diverse expression systems:
Neurological disease models: SCAMP5 missense mutations (e.g., R91W, G180W) are linked to neurodevelopmental disorders and Parkinson’s disease . Recombinant Xenopus SCAMP5 enables mechanistic studies of these mutations.
Autophagy-exosome crosstalk: Used to explore how cells switch between protein degradation pathways under stress .
Evolutionary studies: Comparative analysis with mammalian SCAMP5 homologs reveals conserved secretory pathway mechanisms .
KEGG: xtr:493330
UniGene: Str.2318
SCAMP5 facilitates vesicular trafficking between the trans-Golgi network and plasma membrane, mediating cargo sorting and membrane fusion events. Its tetraspanin structure (four transmembrane domains) enables interactions with SNARE proteins and calcium-sensitive regulators . Researchers confirm its role via:
Knockdown assays: Morpholino oligonucleotides targeting scamp5 mRNA disrupt secretory vesicle formation in oocytes .
Co-immunoprecipitation: SCAMP5 binds Syntaxin-1A (STX1A) in Xenopus egg extracts, validated by Western blotting .
X. tropicalis offers a diploid genome (2n = 20), simplifying genetic manipulation compared to the pseudotetraploid X. laevis (4n = 36) . Key advantages:
Transgenic efficiency: 80–90% germline transmission rates using I-SceI meganuclease .
Gene homology: 85% amino acid identity between X. tropicalis and mammalian SCAMP5 .
Developmental synchrony: Embryos develop uniformly, enabling high-throughput screens for secretory defects .
Maximize soluble protein yield using:
Codon optimization: Replace rare Xenopus tRNA codons (e.g., AGG/AGA arginine) with E. coli-preferred equivalents .
Induction conditions: Low-temperature induction (16°C) with 0.5 mM IPTG reduces inclusion body formation .
Buffer additives: 6% trehalose in storage buffers prevents aggregation during lyophilization .
Discrepancies often arise from post-translational modifications (PTMs) or alternative splicing:
PTM analysis: Treat purified SCAMP5 with PNGase F to remove N-linked glycosylation; observe ~2 kDa shift via SDS-PAGE .
Isoform sequencing: Compare cDNA sequences from X. tropicalis oocytes (e.g., ENSXETT00000023355 vs. ENSXETT00000075981) to identify splice variants .
| Isoform | Length (aa) | Unique Domains | Expression Pattern |
|---|---|---|---|
| ENSXETP...355 | 231 | Full-length tetraspanin | Oocytes, neural tissue |
| ENSXETP...981 | 189 | Truncated C-terminal domain | Early embryos |
To avoid artifacts in fluorescence-based tracking:
Endogenous tag validation: Compare CRISPR knock-in mCherry-SCAMP5 lines with overexpression constructs .
Compartmental markers: Co-stain with Golgi (GM130) and early endosome (EEA1) antibodies .
FRAP controls: Verify fluorescence recovery after photobleaching in the Golgi apparatus (<60% recovery indicates stable membrane association) .
Redundancy complicates phenotype interpretation in knockout models. Solutions include:
Double/Triple Knockouts: Use CRISPR-Cas9 to delete scamp2, scamp3, and scamp5 in F0 mosaics .
Dominant-negative mutants: Overexpress SCAMP5 lacking the N-terminal cytoplasmic domain (Δ1–45 aa) to disrupt oligomerization .
Transcriptomic profiling: RNA-seq of SCAMP5-depleted cells identifies compensatory upregulation of scamp1/4 .
Commercial antibodies often cross-react with SCAMP paralogs. Rigorous validation requires:
Knockout validation: Western blotting using scamp5 CRISPR-Cas9 KO lysates .
Peptide competition: Pre-incubate antibody with 10x molar excess of immunizing peptide (e.g., residues 150–165) .
Immunogold EM: Confirm subcellular localization in Xenopus oocytes .
Detergent screening: Test n-dodecyl-β-D-maltopyranoside (DDM) vs. lauryl maltose neopentyl glycol (LMNG) at 1–2× CMC .
Redox optimization: Include 2 mM TCEP to stabilize cysteine-rich regions .
Lipid supplementation: Reconstitute SCAMP5 into liposomes with 20% cholesterol to mimic native membranes .
Phylogenetic trees: Use MEGA-X to align SCAMP5 sequences across 12 vertebrates .
ConSurf: Identify conserved residues in the second luminal loop (critical for SNARE binding) .
3D homology modeling: SWISS-MODEL templates based on rat SCAMP1 (PDB: 6V7X) .
Focus on domains implicated in trafficking:
Site-directed mutagenesis: Cysteine-to-alanine substitutions in the Cys-rich motif (C158A/C162A) disrupt disulfide bonding .
Circular dichroism: Compare wild-type and mutant SCAMP5 spectra to assess secondary structure loss .
Functional rescue: Inject mutant mRNA into scamp5 MO embryos; quantify secretory vesicle rescue via electron microscopy .